TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 295 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q4 2021. The put-call ratio across all filers is 0.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $2,546,000 | +5.0% | 177,815 | 0.0% | 0.23% | +14.1% |
| Q4 2021 | $2,424,000 | -16.8% | 177,815 | 0.0% | 0.20% | -11.2% |
| Q3 2021 | $2,913,000 | -2.7% | 177,815 | 0.0% | 0.22% | +14.9% |
| Q2 2021 | $2,993,000 | -7.8% | 177,815 | 0.0% | 0.20% | +23.4% |
| Q1 2021 | $3,247,000 | -43.4% | 177,815 | -43.6% | 0.16% | -54.9% |
| Q4 2020 | $5,733,000 | +2.0% | 315,006 | 0.0% | 0.35% | -18.0% |
| Q3 2020 | $5,620,000 | -62.1% | 315,006 | -62.0% | 0.43% | -73.0% |
| Q2 2020 | $14,845,000 | +18.1% | 827,955 | 0.0% | 1.58% | -31.3% |
| Q1 2020 | $12,568,000 | -23.1% | 827,955 | 0.0% | 2.30% | +2.5% |
| Q4 2019 | $16,336,000 | +14.7% | 827,955 | 0.0% | 2.24% | +44.4% |
| Q3 2019 | $14,241,000 | -2.8% | 827,955 | 0.0% | 1.55% | +55.4% |
| Q2 2019 | $14,655,000 | -13.1% | 827,955 | 0.0% | 1.00% | -13.5% |
| Q1 2019 | $16,865,000 | – | 827,955 | – | 1.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Adelphi Capital LLP | 8,958,784 | $176,757,000 | 33.75% |
| Ovata Capital Management Ltd | 879,800 | $17,557,092,000 | 13.04% |
| Paulson & Co. | 13,244,711 | $261,318,000 | 5.64% |
| Glenview Capital Management | 30,582,721 | $603,397,000 | 5.28% |
| MIC CAPITAL PARTNERS (PUBLIC) (US) IM, LLC | 718,028 | $14,167,000 | 4.85% |
| Velanne Asset Management Ltd | 302,694 | $5,972,000 | 3.52% |
| Blackcrane Capital, LLC | 172,708 | $3,408,000 | 2.72% |
| Melqart Asset Management (UK) Ltd | 1,557,000 | $30,720,000 | 2.57% |
| GMT CAPITAL CORP | 3,345,976 | $66,016,000 | 2.55% |
| REDWOOD CAPITAL MANAGEMENT, LLC | 827,955 | $16,336,000 | 2.24% |